To include your compound in the COVID-19 Resource Center, submit it here.

EMERALD city

Affymax hopes new safety data firms up case for peginesatide NDA in dialysis

Shares of Affymax Inc. (NASDAQ:AFFY) edged up last week after reporting new analyses of its Phase III peginesatide data that bolster the

Read the full 228 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE